Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.490
+0.020 (1.36%)
At close: Apr 10, 2026, 4:00 PM EDT
1.520
+0.030 (2.01%)
After-hours: Apr 10, 2026, 7:32 PM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover Autolus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.50, which forecasts a 470.47% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.
Price Target: $8.50 (+470.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +571.14% | Apr 9, 2026 |
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +571.14% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +571.14% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +504.03% | Feb 17, 2026 |
| Needham | Needham | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +571.14% | Jan 12, 2026 |
Financial Forecast
Revenue This Year
139.27M
from 75.39M
Increased by 84.74%
Revenue Next Year
230.85M
from 139.27M
Increased by 65.76%
EPS This Year
-0.93
from -1.08
EPS Next Year
-0.75
from -0.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 175.4M | 335.0M | |||
| Avg | 139.3M | 230.9M | |||
| Low | 116.4M | 141.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 132.6% | 140.5% | |||
| Avg | 84.7% | 65.8% | |||
| Low | 54.4% | 1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.59 | -0.45 | |||
| Avg | -0.93 | -0.75 | |||
| Low | -1.31 | -0.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.